1220 related articles for article (PubMed ID: 32087217)
1. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
Dai Y; Wang S; Chang S; Ren D; Shali S; Li C; Yang H; Huang Z; Ge J
J Mol Cell Cardiol; 2020 May; 142():65-79. PubMed ID: 32087217
[TBL] [Abstract][Full Text] [Related]
2. M2 Macrophage-Derived Exosomes Regulate Myocardial Ischemia-Reperfusion And Pyroptosis Via ROS/NLRP3 Pathway.
Hu H; Qi L; Ren C; Yan S
Heart Surg Forum; 2022 Sep; 25(5):E698-E708. PubMed ID: 36317904
[TBL] [Abstract][Full Text] [Related]
3. Diannexin alleviates myocardial ischemia-reperfusion injury by orchestrating cardiomyocyte oxidative damage, macrophage polarization and fibrotic process by TLR4-NF-kB-mediated inactivation of NLRP3 inflammasome.
Zhang L; Zhao S; Wang Y
Int Immunopharmacol; 2024 Mar; 130():111668. PubMed ID: 38417368
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miR-17-5p from adipose-derived mesenchymal stem cells inhibits abdominal aortic aneurysm by suppressing TXNIP-NLRP3 inflammasome.
Hu J; Jiang Y; Wu X; Wu Z; Qin J; Zhao Z; Li B; Xu Z; Lu X; Wang X; Liu X
Stem Cell Res Ther; 2022 Jul; 13(1):349. PubMed ID: 35883151
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
[TBL] [Abstract][Full Text] [Related]
6. microRNA-129 overexpression in endothelial cell-derived extracellular vesicle influences inflammatory response caused by myocardial ischemia/reperfusion injury.
Zheng S; Wang L; Ma H; Sun F; Wen F
Cell Biol Int; 2021 Aug; 45(8):1743-1756. PubMed ID: 33851774
[TBL] [Abstract][Full Text] [Related]
7. Panaxynol ameliorates cardiac ischemia/reperfusion injury by suppressing NLRP3-induced pyroptosis and apoptosis via HMGB1/TLR4/NF-κB axis.
Ding HS; Huang Y; Qu JF; Wang YJ; Huang ZY; Wang FY; Yi WJ; Liu XX
Int Immunopharmacol; 2023 Aug; 121():110222. PubMed ID: 37343367
[TBL] [Abstract][Full Text] [Related]
8. Formononetin ameliorates myocardial ischemia/reperfusion injury in rats by suppressing the ROS-TXNIP-NLRP3 pathway.
Wang DS; Yan LY; Yang DZ; Lyu Y; Fang LH; Wang SB; Du GH
Biochem Biophys Res Commun; 2020 May; 525(3):759-766. PubMed ID: 32145915
[TBL] [Abstract][Full Text] [Related]
9. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury.
Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J
Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584
[TBL] [Abstract][Full Text] [Related]
10. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
[TBL] [Abstract][Full Text] [Related]
11. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury.
Liu Y; Lian K; Zhang L; Wang R; Yi F; Gao C; Xin C; Zhu D; Li Y; Yan W; Xiong L; Gao E; Wang H; Tao L
Basic Res Cardiol; 2014; 109(5):415. PubMed ID: 25015733
[TBL] [Abstract][Full Text] [Related]
12. AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages.
Liu Y; Lou G; Li A; Zhang T; Qi J; Ye D; Zheng M; Chen Z
EBioMedicine; 2018 Oct; 36():140-150. PubMed ID: 30197023
[TBL] [Abstract][Full Text] [Related]
13. Aesculin suppresses the NLRP3 inflammasome-mediated pyroptosis via the Akt/GSK3β/NF-κB pathway to mitigate myocardial ischemia/reperfusion injury.
Xu XN; Jiang Y; Yan LY; Yin SY; Wang YH; Wang SB; Fang LH; Du GH
Phytomedicine; 2021 Nov; 92():153687. PubMed ID: 34482222
[TBL] [Abstract][Full Text] [Related]
14. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway.
Shen S; He F; Cheng C; Xu B; Sheng J
Biomed Pharmacother; 2021 Jan; 133():110990. PubMed ID: 33232925
[TBL] [Abstract][Full Text] [Related]
15. Octreotide and melatonin alleviate inflammasome-induced pyroptosis through inhibition of TLR4-NF-κB-NLRP3 pathway in hepatic ischemia/reperfusion injury.
El-Sisi AEE; Sokar SS; Shebl AM; Mohamed DZ; Abu-Risha SE
Toxicol Appl Pharmacol; 2021 Jan; 410():115340. PubMed ID: 33264646
[TBL] [Abstract][Full Text] [Related]
16. miR-155-5p accelerates cerebral ischemia-reperfusion inflammation injury and cell pyroptosis via DUSP14/ TXNIP/NLRP3 pathway.
Shi Y; Li Z; Li K; Xu K
Acta Biochim Pol; 2022 Nov; 69(4):787-793. PubMed ID: 36441582
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca
Zheng X; Li J; Fan Q; Zhao X; Chen K
Int J Cardiol; 2021 Sep; 338():185-195. PubMed ID: 33731281
[TBL] [Abstract][Full Text] [Related]
18. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
